SequelSEC

BiomX Inc. PHGE

Services-Prepackaged Software · CIK 0001739174 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$332.00K
Fiscal year ended 2026-06-30
Operating income
-$5.41M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$11.90MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.18Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Prepackaged Software filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.87x27th

BiomX Inc. (PHGE) reported revenue of $332.00K and net income of -$3.85M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BiomX Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Prepackaged Software.

Income

BiomX Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$332.00K
Cost of revenue$235.00K
Gross profit$97.00K
Operating income-$5.41M
Net income-$3.85M
Research & developmentUnavailable
Weighted-average diluted sharesshares 10.31M
Pretax income-$3.85M
Income tax expenseUnavailable
Diluted EPS$0.37
Selling, general & administrativeUnavailable
General & administrative$5.38M
Selling & marketingUnavailable

Balance

BiomX Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$347.00K
Total assets$28.19M
Current assets$2.42M
Total liabilities$10.56M
Current liabilities$10.18M
Total equity incl. NCI$17.62M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$327.00K
GoodwillUnavailable
Long-term debt$247.00K
Accounts payableUnavailable

Cash flow

BiomX Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flowUnavailable
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

BiomX Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin29.2%
Operating margin-1630.7%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.24x
Revenue YoY growthUnavailable
Net margin-1158.4%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equity0.01x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PHGE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-19View SEC filing
10-Q · Filed 2026-05-20View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.